SANTEN PHARMACEUTICAL CO.,LTD. Logo

SANTEN PHARMACEUTICAL CO.,LTD.

A global company specializing in pharmaceuticals and medical devices for ophthalmology.

4536 | T

Overview

Corporate Details

ISIN(s):
JP3336000009
LEI:
Country:
Japan
Address:
大阪市北区大深町4番20号

Description

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-08-08 08:06
確認書
Japanese DOC 8.8 KB
2022-08-08 08:04
四半期報告書-第111期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese DOC 340.8 KB
2022-06-24 08:12
確認書
Japanese DOC 8.7 KB
2022-06-24 08:10
内部統制報告書-第110期(令和3年4月1日-令和4年3月31日)
Japanese DOC 23.9 KB
2022-06-24 08:08
有価証券報告書-第110期(令和3年4月1日-令和4年3月31日)
Japanese DOC 1.7 MB
2022-02-14 07:04
四半期報告書-第110期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese DOC 397.1 KB
2021-11-10 06:04
四半期報告書-第110期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese DOC 409.9 KB
2021-08-11 06:33
四半期報告書-第110期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese DOC 329.5 KB
2021-06-25 09:45
確認書
Japanese DOC 8.7 KB
2021-06-25 09:44
内部統制報告書-第109期(令和2年4月1日-令和3年3月31日)
Japanese DOC 24.0 KB
2021-06-25 09:42
有価証券報告書-第109期(令和2年4月1日-令和3年3月31日)
Japanese DOC 1.7 MB
2021-02-08 06:09
四半期報告書-第109期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese DOC 543.1 KB
2020-11-11 02:11
四半期報告書-第109期第2四半期(令和2年7月1日-令和2年9月30日)
Japanese DOC 549.8 KB
2020-08-07 03:07
四半期報告書-第109期第1四半期(令和2年4月1日-令和2年6月30日)
Japanese DOC 485.1 KB
2020-06-24 08:57
有価証券報告書-第108期(平成31年4月1日-令和2年3月31日)
Japanese DOC 1.7 MB

Automate Your Workflow. Get a real-time feed of all SANTEN PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANTEN PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANTEN PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.